ATE415403T1 - Verfahren zur herstellung von alphaformkristallen von sapropterinhydrochlorid - Google Patents

Verfahren zur herstellung von alphaformkristallen von sapropterinhydrochlorid

Info

Publication number
ATE415403T1
ATE415403T1 AT06732122T AT06732122T ATE415403T1 AT E415403 T1 ATE415403 T1 AT E415403T1 AT 06732122 T AT06732122 T AT 06732122T AT 06732122 T AT06732122 T AT 06732122T AT E415403 T1 ATE415403 T1 AT E415403T1
Authority
AT
Austria
Prior art keywords
crystals
hydrochloride
sapropterine
alphaform
producing
Prior art date
Application number
AT06732122T
Other languages
English (en)
Inventor
Katsumi Hotoda
Hiroomi Kiyono
Shinnosuke Tazawa
Original Assignee
Shiratori Pharm
Daiichi Asubio Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shiratori Pharm, Daiichi Asubio Pharma Co Ltd filed Critical Shiratori Pharm
Application granted granted Critical
Publication of ATE415403T1 publication Critical patent/ATE415403T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D475/00Heterocyclic compounds containing pteridine ring systems
    • C07D475/02Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4
    • C07D475/04Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AT06732122T 2005-04-14 2006-04-13 Verfahren zur herstellung von alphaformkristallen von sapropterinhydrochlorid ATE415403T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2005116687 2005-04-14

Publications (1)

Publication Number Publication Date
ATE415403T1 true ATE415403T1 (de) 2008-12-15

Family

ID=36617398

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06732122T ATE415403T1 (de) 2005-04-14 2006-04-13 Verfahren zur herstellung von alphaformkristallen von sapropterinhydrochlorid

Country Status (15)

Country Link
US (1) US8039617B2 (de)
EP (1) EP1869048B8 (de)
JP (1) JP4980230B2 (de)
KR (1) KR101258430B1 (de)
CN (1) CN101160310B (de)
AT (1) ATE415403T1 (de)
AU (1) AU2006237936B2 (de)
BR (1) BRPI0608863B1 (de)
CA (1) CA2604818C (de)
DE (1) DE602006003883D1 (de)
DK (1) DK1869048T3 (de)
ES (1) ES2317529T3 (de)
PL (1) PL1869048T3 (de)
PT (1) PT1869048E (de)
WO (1) WO2006112495A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2711444C (en) 2008-01-07 2017-12-12 Biomarin Pharmaceutical Inc. Method of synthesizing tetrahydrobiopterin
US9216178B2 (en) 2011-11-02 2015-12-22 Biomarin Pharmaceutical Inc. Dry blend formulation of tetrahydrobiopterin
CN108033963A (zh) * 2017-12-29 2018-05-15 天津凯莱英制药有限公司 沙丙喋呤二盐酸盐晶型b及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60178887A (ja) 1984-02-23 1985-09-12 Kanegafuchi Chem Ind Co Ltd 5,6,7,8−テトラヒドロ−l−ビオプテリンの製造法
JPS61172876A (ja) * 1985-01-28 1986-08-04 Shiratori Seiyaku Kk (6r)−テトラヒドロ−l−バイオプテリンの製造法
CA1262347A (en) * 1985-01-28 1989-10-17 Suntory Limited Preparation process of (6r)-tetrahydro-l-biopterin
JP2711828B2 (ja) 1996-06-25 1998-02-10 白鳥製薬株式会社 (6r)−テトラヒドローl−バイオプテリン塩酸塩の製造法
CA2678125C (en) * 2003-11-17 2014-10-14 Merck Eprova Ag Crystalline forms of (6r)-l-erythro-tetrahydrobiopterin dihydrochloride

Also Published As

Publication number Publication date
EP1869048A1 (de) 2007-12-26
JP2008535770A (ja) 2008-09-04
WO2006112495A1 (en) 2006-10-26
KR101258430B1 (ko) 2013-04-26
DK1869048T3 (da) 2009-03-09
CN101160310A (zh) 2008-04-09
CA2604818C (en) 2012-12-04
CN101160310B (zh) 2010-05-26
BRPI0608863B1 (pt) 2022-09-27
US8039617B2 (en) 2011-10-18
CA2604818A1 (en) 2006-10-26
JP4980230B2 (ja) 2012-07-18
US20090270619A1 (en) 2009-10-29
PL1869048T3 (pl) 2009-05-29
DE602006003883D1 (de) 2009-01-08
EP1869048B1 (de) 2008-11-26
AU2006237936A1 (en) 2006-10-26
AU2006237936B2 (en) 2011-06-16
EP1869048B8 (de) 2009-04-15
ES2317529T3 (es) 2009-04-16
BRPI0608863A2 (pt) 2010-02-02
KR20080000582A (ko) 2008-01-02
PT1869048E (pt) 2009-03-05

Similar Documents

Publication Publication Date Title
ES2579827T3 (es) Composición de estevia
NO20082610L (no) Trihydrokloridformer av et dihydropteridonderivat og metoder for fremstilling
DE502005002356D1 (de) Neue 2-benzylaminodihydropteridinone, verfahren zu deren herstellung und deren verwendung als arzneimittel
DE502006006107D1 (de) Amid substituierte 8-n-benzimidazole, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
UA102236C2 (uk) Похідні еритропоетин-міметичного пептиду та їх фармацевтичні солі, їх одержання і застосування
DE502004006603D1 (de) Verfahren zur herstellung von cyclododecanon
ECSP13013073A (es) Derivados de benzamida sustituida
JP2013502377A5 (de)
EP1582514A4 (de) Verfahren zur herstellung eines glutaminsäurederivats und eines pyroglutaminsäurederivats und neues zwischenprodukt für die herstellung
ATE477798T1 (de) Verwendung von agomelatin zur herstellung von medikamenten zur behandlung der generalisierten angststörung
WO2009018065A3 (en) Novel glucokinase activators and methods of using same
DE502007001868D1 (de) Verfahren zur gekoppelten herstellung von chlor und isocyanaten
EA201070228A1 (ru) Тразодон и гидрохлорид тразодона в очищенной форме
ATE415403T1 (de) Verfahren zur herstellung von alphaformkristallen von sapropterinhydrochlorid
NO20080812L (no) Fremgangsmate for fremstilling av 4 β-amino-4'demetyl-4-4-desoksy podofyllotoksin
DK1664123T4 (da) Storskalafremstilling af alfa-1-proteinaseinhibitor og anvendelse deraf
NO20075930L (no) Fremgangsmate for fremstilling av alkalimetallsalt
BRPI0507886A (pt) método de purificação de albumina compreendendo uma etapa de nanofiltração, solução e composição para uso terapêutico contendo-o
ATA4642004A (de) Zeolith in der biogasgewinnung
RU2006109914A (ru) Способ получения супрамолекулярного геля
ATE548446T1 (de) Herstellung und reinigung von protein a ohne die verwendung von tierischen komponenten
CY1113016T1 (el) Μεθοδος για παραγωγη δενδριτικων κυτταρων με εφαρμογη μειωμενης θερμοκρασιας
ATE523490T1 (de) Verfahren zur herstellung von pleuromutilinen
ATE478106T1 (de) Verfahren zur herstellung von polyarylat mit hoher wärmebeständigkeit und hoher transparenz
RU2014116875A (ru) Способ получения 1,2-бензизотиазолин-3-она

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1869048

Country of ref document: EP